Toggle Main Menu Toggle Search

ePrints

Browsing publications by Professor Michael Griffin

Newcastle AuthorsTitleYearFull text
Alexander Phillips
Professor Michael Griffin
A tale of three stents: Aortic stenting prior to oesophagectomy after oesophageal stents2018
Dr Maziar Navidi
Alexander Phillips
Professor Michael Griffin
Dr Alastair Greystoke
Dr Kate Sumpter
et al.
Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer2018
Alexander Phillips
Barry Dent
Dr Maziar Navidi
Arul Immanuel
Professor Michael Griffin
et al.
Trainee Involvement in Ivor Lewis Esophagectomy Does Not Negatively Impact Outcomes2018
Alexander Phillips
Dr Maziar Navidi
Professor Michael Griffin
Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy2017
Professor Michael Griffin
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)2017
Alexander Phillips
Dr Maziar Navidi
Professor Michael Griffin
Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy2017
Dr Rhona Sinclair
Alexander Phillips
Dr Maziar Navidi
Professor Michael Griffin
Dr Christopher Snowden
et al.
Pre-operative variables including fitness associated with complications after oesophagectomy2017
Professor Michael Griffin
Dr Kate Sumpter
A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) +/- lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948)2016
Dr Lorna Dunn
Professor Alastair Burt
Professor Michael Griffin
Columnar Metaplasia in the Esophageal Remnant After Esophagectomy A Common Occurrence and a Valuable Insight Into the Development of Barrett Esophagus2016
Marina Saisana
Professor Michael Griffin
Dr Felicity May
Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation2016
1234567891011